Laboratorios Farma | ROVI - Equity Capital And Reserves



Laboratorios Farma reported EUR574.72M in Equity Capital and Reserves for its fiscal semester ending in June of 2025.


Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.06M 661K Dec/2024
Almirall EUR 1.46B 37.19M Jun/2025
Avita Medical AUD 4.5M 19.42M Dec/2024
Dianthus Therapeutics USD 303.08M 49.4M Jun/2025
Ionis Pharmaceuticals USD 631.72M 156M Jun/2025
IQVIA Holdings USD 5.78B 199M Jun/2025
Laboratorios Farma EUR 574.72M 6.82M Jun/2025
Moderna USD 9.4B 667M Jun/2025
Organon & Co USD 733M 191M Jun/2025
Pharma Mar EUR 201.53M 4.06M Jun/2025
Revvity USD 7.64B 29.74M Mar/2025
Tectonic Therapeutic USD 283.77M 142.99M Jun/2025
Viatris USD 15.57B 79.9M Jun/2025
Xeris Pharmaceuticals USD -19300000 10.32M Jun/2025